બોનકાસ્ટ-એલ ટેબ્લેટ

ઉત્પાદન વર્ણન

PRODUCT INTRODUCTION

Bonkast-L Tablet is a combination medicine used in the treatment of allergic symptoms such as runny nose, stuffy nose, sneezing, itching, swelling, watery eyes and congestion or stuffiness. It also reduces inflammation in the airways and make breathing easier.

Bonkast-L Tablet is taken with or without food in a dose and duration as advised by the doctor. The dose you are given will depend on your condition and how you respond to the medicine. You should keep taking this medicine for as long as your doctor recommends. If you stop treatment too early your symptoms may come back and your condition may worsen. Let your healthcare team know about all other medications you are taking as some may affect, or be affected by this medicine.

The most common side effects are nausea, diarrhea, vomiting, dryness in the mouth, headache, skin rash, flu-like symptoms, and fatigue. Most of these are temporary and usually resolve with time. Contact your doctor straight away if you are at all concerned about any of these side effects. This medicine may cause dizziness and sleepiness, so do not drive or do anything that requires mental focus until you know how this medicine affects you. Avoid drinking alcohol while taking this medicine as it can worsen your sleepiness.

Never support self-medication or recommend your medicine to another person. It is beneficial to have plenty of fluids while taking this medication. Before you start taking this medicine it is important to inform your doctor if you are suffering from kidney disease.

USES OF BONKAST-L TABLET

• Treatment of Allergic skin conditions
• Treatment of Sneezing and runny nose due to allergies
• Treatment of Hay fever

BENEFITS OF BONKAST-L TABLET

SIDE EFFECTS OF BONKAST-L TABLET

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you™re worried about them

Common side effects of Bonkast-L

• Nausea
• Diarrhea
• Dryness in mouth
• Fatigue
• Headache
• Skin rash
• Sleepiness
• Vomiting
• Upper respiratory tract infection
• Sore throat
• Fever
• Abdominal pain
• Increased liver enzymes

HOW TO USE BONKAST-L TABLET

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Bonkast-L Tablet may be taken with or without food, but it is better to take it at a fixed time.

HOW BONKAST-L TABLET WORKS

Bonkast-L Tablet is a combination of two medicines: Levocetirizine and Montelukast, which relieves sneezing and runny nose due to allergies. Levocetirizine is an antiallergic which blocks a chemical messenger (histamine) responsible for runny nose, watery eyes and sneezing. Montelukast is a leukotriene antagonist. It works by blocking another chemical messenger (leukotriene). This reduces inflammation (swelling) in the airways and nose, and improves symptoms.

SAFETY ADVICE

CAUTION

Caution is advised when consuming alcohol with Bonkast-L Tablet. Please consult your doctor.

SAFE IF PRESCRIBED

Bonkast-L Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.

UNSAFE

Bonkast-L Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.

UNSAFE

Bonkast-L Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.

CAUTION

Bonkast-L Tablet should be used with caution in patients with kidney disease. Dose adjustment of Bonkast-L Tablet may be needed. Please consult your doctor.
Use of Bonkast-L Tablet is not recommended in patients with severe kidney disease.

CAUTION

Bonkast-L Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Bonkast-L Tablet may be needed. Please consult your doctor.
Limited information is available on the use of Bonkast-L Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate liver disease.